Ledger.Open graph →
SEC Form D · filed August 12, 2021

Anivive Lifesciences, Inc

Offering
$44.3M
Sold
$44.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
LONG BEACH, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Rick Haugen · Long Beach, CADirectorDylan Balsz · Long Beach, CAExec · DirectorDavid Bruyette · Long Beach, CAExec · DirectorLynne Doti · Long Beach, CADirectorScott Whitcup · Long Beach, CADirectorCheryl Collett · Long Beach, CAExecDylan Balsz · Long Beach, CAExec · DirectorRick Haugen · Long Beach, CADirectorLynne Doti · Long Beach, CADirectorDavid Bruyette · Long Beach, CAExec · DirectorGlenn Stearns · Irvine, CADirectorCheryl Collett · Long Beach, CAExecRobert Bishop · Vancouver, British Columbia, CanadaDirectorGlenn Stearns · Irvine, CADirectorScott Whitcup · Long Beach, CADirectorRobert Bishop · South Bend, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗